[ABCL] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ABCL] AbCellera Biologics Inc.
Announcement Date
04-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -34.18%
YoY- -123.79%
Quarter Report
ABCL's Result
ABCL's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
Revenue 9,954 12,192 316,581 202,741 4,657 2,479 32.01%
PBT -42,747 -48,148 230,809 161,487 -2,093 -303 168.79%
Tax -2,137 -8,038 62,236 44,266 0 0 -
NP -40,610 -40,110 168,573 117,221 -2,093 -303 166.05%
Tax Rate - - -26.96% -27.41% - - -
Total Cost 50,564 52,302 148,008 85,520 6,750 2,782 78.49%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
NP Margin -407.98 -328.99 53.25 57.82 -44.94 -12.22 101.54%
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 CAGR
EPS -0.14 -0.14 0.54 0.43 -0.01 -0.00 -
EPS Diluted -0.14 -0.14 0.54 0.37 -0.01 -0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.